Systemic and compartmentalised immune responses in a Leishmania braziliensis-macaque model of self-healing cutaneous leishmaniasis

Veterinary Immunology and Immunopathology

Volumn 137, Issue 1-2, 2010, Pages 149-154

  de Campos, S N ^a   Souza Lemos, C ^a   Teva, A ^a   Porrozzi, R ^a   Grimaldi, G ^a  

^a INSTITUTO OSWALDO CRUZ   (Brazil)

Author keywords

Human like granulomatous response; Leishmania braziliensis cutaneous infection; Primate model

Indexed keywords

GAMMA INTERFERON; INTERLEUKIN 10; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIGEN SPECIFICITY; ARTICLE; CD4+ CD25+ T LYMPHOCYTE; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CELLULAR IMMUNITY; CYTOKINE PRODUCTION; EFFECTOR CELL; EX VIVO STUDY; FLOW CYTOMETRY; GRANULOMA; IMMUNE RESPONSE; IMMUNOSTIMULATION; IN VITRO STUDY; INFLAMMATION; LEISHMANIA BRAZILIENSIS; LEUKOCYTE; LYMPH NODE; NONHUMAN; NOSE MUCOSA; REGULATORY T LYMPHOCYTE; RHESUS MONKEY; SKIN LEISHMANIASIS; TUMOR GROWTH; WOUND HEALING;

LEISHMANIA BRAZILIENSIS; MACACA; MACACA MULATTA; PRIMATES;

EID: 77955552995     PISSN: 01652427     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.vetimm.2010.04.009     Document Type: Article

References (22)

1. - Th1 cells are the source of IL-10-mediated immune suppression in chronic cutaneous leishmaniasis. J. Exp. Med. 2007, 204:285-297.
2. Barbosa Reis A., Martins-Filho O.A., Teixeira-Carvalho A., Giunchetti R.C., Carneiro C.M., Mayrink W., Tafuri W.L., Corrêa-Oliveira R. Systematic and compartmentalized immune response in canine visceral leishmaniasis. Vet. Immunol. Immunopathol. 2009, 128:87-95.
3. Barral A., Barral-Neto M., Almeida, Ribeiro de Jesus A., Grimaldi G., Netto M.E., Santos I., Bacellar O., Carvalho E.M. Lymphadenopathy associated with Leishmania braziliensis cutaneous infection. Am. J. Trop. Med. Hyg. 1992, 47:587-592.
4. Barral A., Jesus A.R., Almeida R.P., Carvalho E.M., Barral-Neto M., Costa J.M., Badaró R., Rocha H., Johnson W.D. Evaluation of T-cell subsets in the lesion infiltrates of human cutaneous and mucocutaneous leishmaniasis. Parasite Immunol. 1987, 9:487-497.
5. + regulatory T cells control Leishmania major persistence and immunity. Nature 2002, 420:502-507.
6. Bromley S.K., Mempel T.R., Luster A.D. Orchestrating the orchestrators: chemokines in control of T cell traffic. Nat. Immunol. 2008, 9:970-980.
7. + T cells in skin lesions of patients with cutaneous leishmaniasis exhibit phenotypic and functional characteristics of natural regulatory T cells. J. Infect. Dis. 2006, 193:1313-1322.
8. Choi B.-S., Kropf P. Evaluation of T cell responses in healing and non-healing leishmaniasis reveals differences in T helper cell polarization ex vivo and in vitro. Parasite Immunol. 2009, 31:199-209.
9. Cupolillo E., Brahim L.R., Toaldo C.B., Oliveira-Neto M.P., de Brito M.E.F., Falqueto A., Naiff M.F., Grimaldi G. Genetic polymorphism and molecular epidemiology of Leishmania (Viannia) braziliensis from different host and geographic areas in Brazil. J. Clin. Microbiol. 2003, 41:3126-3132.
10. Grimaldi G. The utility of rhesus monkey (Macaca mulatta) and other non-human primate models for preclinical testing of Leishmania vaccine candidates-a Review. Mem. Inst. Oswaldo Cruz 2008, 103:629-644.
11. Grimaldi G., Tesh R.B. Leishmaniasis of the New World: current concepts and implications for future research. Clin. Microbiol. Rev. 1993, 6:230-250.
12. Lima H.C., Vasconcelos A.W., David J.R., Lerner E.A. American cutaneous leishmaniasis: in situ characterization of the cellular immune response with time. Am. J. Trop. Med. Hyg. 1994, 50:743-747.
13. Mackay C.R. Moving targets: cell migration inhibitors as new anti-inflammatory therapies. Nat. Immunol. 2008, 9:988-999.
14. Murray H.W., Flanders K.C., Donaldson D.D., Sypeck J.P., Gotwals P.J., Liu J., Ma X. Antagonizing deactivating cytokines to enhance host defense and chemotherapy in experimental visceral leishmaniasis. Infect. Immun. 2005, 73:3903-3911.
15. Muse Davis J., Ramakrishnan L. The role of the granuloma in expansion and dissemination of early tuberculous infection. Cell 2009, 136:37-49.
16. Nylen S., Sacks D. Interleukin-10 and the pathogenesis of human visceral leishmaniasis. Trends Immunol. 2007, 28:378-384.
17. Pirmez C., Yamamura M., Uyemura K., Paes-Oliveira M., Conceição-Silva F., Modlin R.L. Cytokine patterns in the pathogenesis of human leishmaniasis. J. Clin. Invest. 1993, 91:1390-1395.
18. Sacks D., Noben-Trauth N. The immunology of susceptible and resistance to Leishmania major in mice. Nat. Rev. Immunol. 2002, 2:845-858.
19. Sojka D.K., Lazarski C.A., Huang Y.-H., Bromberg I., Hughson A., Fowell D.J. Regulation of immunity at tissue sites of inflammation. Immunol. Res. 2009, 45:239-250.
20. Souza-Lemos C., de-Campos S.N., Teva A., Côrte-Real S., Fonseca E.C., Porrozzi R., Grimaldi G. Dynamics of immune granuloma formation in a Leishmania braziliensis-induced self-limiting cutaneous infection in the primate Macaca mulatta. J. Pathol. 2008, 216:375-386.
21. Teva A., Porrozzi R., Cupolillo E., Pirmez C., Oliveira-Neto M.P., Grimaldi G. Leishmania (Viannia) braziliensis induced chronic granulomatous cutaneous lesions affecting the nasal mucosa in the rhesus monkey (Macaca mulatta) model. Parasitology 2003, 127:437-447.
22. Vanloubbeeck Y., Jones D.E. The immunology of Leishmania infection and the implications for vaccine development. Ann. N. Y. Acad. Sci. 2004, 1026:267-272.